Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Canaccord Genuity Initiates Coverage of Spectrum Brands Holdings (SPB) with Buy Recommendation
On March 30, 2023, Canaccord Genuity initiated coverage of Spectrum Brands Holdings with a Buy recommendation. Analyst Price Forecast Suggests 27.12% Upside As of March
TD Cowen Initiates Coverage of Waste Management (WM) with Outperform Recommendation
On March 30, 2023, TD Cowen initiated coverage of Waste Management with a Outperform recommendation. Analyst Price Forecast Suggests 9.32% Upside As of March 30,
HC Wainwright & Co. Initiates Coverage of Legend Biotech (LEGN) with Buy Recommendation
On March 29, 2023, HC Wainwright & Co. initiated coverage of Legend Biotech with a Buy recommendation. Analyst Price Forecast Suggests 51.50% Upside As of
UBS Initiates Coverage of Edwards Lifesciences (EW) with Neutral Recommendation
On March 29, 2023, UBS initiated coverage of Edwards Lifesciences with a Neutral recommendation. Analyst Price Forecast Suggests 9.47% Upside As of March 29, 2023,
UBS Initiates Coverage of DexCom (DXCM) with Buy Recommendation
On March 29, 2023, UBS initiated coverage of DexCom with a Buy recommendation. Analyst Price Forecast Suggests 18.96% Upside As of March 28, 2023, the
Wells Fargo Initiates Coverage of UDR (UDR) with Overweight Recommendation
On March 29, 2023, Wells Fargo initiated coverage of UDR with a Overweight recommendation. Analyst Price Forecast Suggests 23.08% Upside As of March 28, 2023,
Oppenheimer Initiates Coverage of Trane Technologies (TT) with Perform Recommendation
On March 28, 2023, Oppenheimer initiated coverage of Trane Technologies with a Perform recommendation. Analyst Price Forecast Suggests 8.38% Upside As of March 29, 2023,
Benchmark Initiates Coverage of Repligen (RGEN) with Buy Recommendation
On March 28, 2023, Benchmark initiated coverage of Repligen with a Buy recommendation. Analyst Price Forecast Suggests 23.54% Upside As of March 29, 2023, the
Evercore ISI Group Initiates Coverage of Astria Therapeutics (ATXS) with Outperform Recommendation
On March 28, 2023, Evercore ISI Group initiated coverage of Astria Therapeutics with a Outperform recommendation. Analyst Price Forecast Suggests 114.24% Upside As of March
B of A Securities Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation
On March 28, 2023, B of A Securities initiated coverage of Foghorn Therapeutics with a Buy recommendation. Analyst Price Forecast Suggests 254.32% Upside As of